01789 AK MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 4.10X | Oper Margin | 26.6% |
|---|---|---|---|
| LT Debt/Equity | 0.3% | Net Margin | 22.9% |
| Total Debt/Equity | 3.0% | Return on Equity | 11.6% |
| Price/Book | 2.23X | Return on Assets | 9.3% |
| (HKD 6.430) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 377.45 | 291.32 | 200.72 | 229.59 | 113.28 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +29.6 | +45.1 | -12.6 | +102.7 | -69.6 |
| Earnings Per Share (HKD) | 0.338 | 0.261 | 0.18 | 0.207 | 0.102 |
| Earnings Per Share Growth (%) | +29.4 | +44.8 | -12.9 | +103.3 | -69.9 |
| Dividend Per Share (HKD) | 0.118 | 0.072 | 0.045 | 0.060 | 0.025 |
| P/E* (X) | 19.03 | 24.63 | 35.66 | 31.06 | 63.16 |
| Yield (%) | 1.84 | 1.12 | 0.70 | 0.93 | 0.39 |
| Dividend Share (%) | 34.92 | 27.58 | 24.96 | 28.99 | 24.56 |
| Book NAV (HKD) | 2.885 | 2.499 | 2.350 | 2.255 | 2.227 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,482 | 1,346 | +10.1 | 1,094 |
| Operating Result | 394.979 | 319.822 | +23.5 | 231.117 |
| Profit Before Taxation | 394.979 | 319.822 | +23.5 | 231.117 |
| Taxation | 55.885 | 45.896 | +21.8 | 49.013 |
| Profit /( Loss) After Taxation | 339.094 | 273.926 | +23.8 | 182.104 |
| Net Profit | 339.094 | 273.926 | +23.8 | 182.104 |
| Earnings Per Share () | 0.3379 | 0.2611 | +29.4 | 0.1803 |
| Dividend Per Share () | 0.1180 | 0.0720 | +63.9 | 0.0450 |
| Announcement Date | 2026-03-25 | 2025-03-26 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
